View in EDS PDF Full Text

Correlation Between First-line Immunotherapy and Second-line TKI Outcomes in Metastatic Renal Cell Carcinoma.

Saved in:
Bibliographic Details
Title: Correlation Between First-line Immunotherapy and Second-line TKI Outcomes in Metastatic Renal Cell Carcinoma.
Authors: Sugimoto K; Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan., Minami T; Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan., Nukaya T; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan., Maenosono R; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Mori K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yamanoi T; Department of Urology, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan., Nishimura S; Department of Urology, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan., Takahara K; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan., Fujita K; Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan., Group OBOTJS; Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan.; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.; Department of Urology, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Source: Cancer diagnosis & prognosis [Cancer Diagn Progn] 2025 Oct 30; Vol. 5 (6), pp. 735-740. Date of Electronic Publication: 2025 Oct 30 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 9918316186306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-7787 (Electronic) Linking ISSN: 27327787 NLM ISO Abbreviation: Cancer Diagn Progn Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41179324
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Correlation Between First-line Immunotherapy and Second-line TKI Outcomes in Metastatic Renal Cell Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sugimoto+K%22">Sugimoto K</searchLink>; Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.<br /><searchLink fieldCode="AU" term="%22Minami+T%22">Minami T</searchLink>; Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.<br /><searchLink fieldCode="AU" term="%22Nukaya+T%22">Nukaya T</searchLink>; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan.<br /><searchLink fieldCode="AU" term="%22Maenosono+R%22">Maenosono R</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan.<br /><searchLink fieldCode="AU" term="%22Tsujino+T%22">Tsujino T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan.<br /><searchLink fieldCode="AU" term="%22Mori+K%22">Mori K</searchLink>; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yanagisawa+T%22">Yanagisawa T</searchLink>; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yamanoi+T%22">Yamanoi T</searchLink>; Department of Urology, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Nishimura+S%22">Nishimura S</searchLink>; Department of Urology, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Takahara+K%22">Takahara K</searchLink>; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan.<br /><searchLink fieldCode="AU" term="%22Fujita+K%22">Fujita K</searchLink>; Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.<br /><searchLink fieldCode="AU" term="%22Group+OBOTJS%22">Group OBOTJS</searchLink>; Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan.; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.; Department of Urology, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918316186306676%22">Cancer diagnosis & prognosis</searchLink> [Cancer Diagn Progn] 2025 Oct 30; Vol. 5 (6), pp. 735-740. <i>Date of Electronic Publication: </i>2025 Oct 30 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22International+Institute+of+Anticancer+Research%22">International Institute of Anticancer Research </searchLink><i>Country of Publication: </i>Greece <i>NLM ID: </i>9918316186306676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2732-7787 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227327787%22">27327787 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Diagn Progn <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41179324
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.21873/cdp.10488
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 735
    Titles:
      – TitleFull: Correlation Between First-line Immunotherapy and Second-line TKI Outcomes in Metastatic Renal Cell Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sugimoto K
      – PersonEntity:
          Name:
            NameFull: Minami T
      – PersonEntity:
          Name:
            NameFull: Nukaya T
      – PersonEntity:
          Name:
            NameFull: Maenosono R
      – PersonEntity:
          Name:
            NameFull: Tsujino T
      – PersonEntity:
          Name:
            NameFull: Mori K
      – PersonEntity:
          Name:
            NameFull: Yanagisawa T
      – PersonEntity:
          Name:
            NameFull: Yamanoi T
      – PersonEntity:
          Name:
            NameFull: Nishimura S
      – PersonEntity:
          Name:
            NameFull: Takahara K
      – PersonEntity:
          Name:
            NameFull: Fujita K
      – PersonEntity:
          Name:
            NameFull: Group OBOTJS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 10
              Text: 2025 Oct 30
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2732-7787
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Cancer diagnosis & prognosis
              Type: main
ResultId 1